# Verily

**Source:** https://geo.sig.ai/brands/verily  
**Vertical:** Digital Health  
**Subcategory:** Precision Health AI  
**Tier:** Leader  
**Website:** verily.com  
**Last Updated:** 2026-04-14

## Summary

Raised $300M (Mar 2026) led by Series X Capital. Became independent corporation; Alphabet now minority investor. Partners include Samsung Galaxy Watch 8 and Salesforce.

## Company Overview

Verily is a precision health AI company that became independent from Alphabet (Google's parent) in March 2026 when it raised $300 million led by Series X Capital, transitioning Alphabet to a minority investor. The independence marks a major strategic inflection: Verily now competes as a standalone health AI platform rather than operating as a Google moonshot project, with the commercial accountability that comes with external capital and institutional investors.

The company's platform harmonizes disparate health data — wearables, EHR, genomics, and clinical trial data — for AI-driven research and care workflows. Partnerships with Samsung Galaxy Watch 8 and Salesforce give Verily real-world data integration at scale: Samsung's Watch 8 writes health data directly to Verily's Health Signals platform, while Salesforce integration brings Verily's AI into health system CRM and care team workflows.

Verily's precision health thesis — that continuous, multi-modal health data enables earlier disease detection and more personalized treatment — is a long-cycle bet that Alphabet's support helped sustain. With independence, the company must now prove commercial value on a shorter timeline, which is likely to accelerate its focus on deployable AI tools for health systems and biopharma rather than basic research.

## Frequently Asked Questions

### What does Verily do?
Precision health AI platform — harmonizes wearables, EHR, genomics, and trial data for AI-driven research and care workflows, with integrations to Samsung Galaxy Watch 8 and Salesforce.

### What changed for Verily in 2026?
Became an independent corporation after raising $300M led by Series X Capital, with Alphabet transitioning to a minority investor from majority owner.

### Who backs Verily?
Series X Capital led the 2026 $300M round; Alphabet remains a minority investor. Prior investors include Temasek, Ontario Teachers, and Johnson & Johnson.

### What partnerships does Verily have?
Samsung Galaxy Watch 8 writes health data to Verily's Health Signals platform; Salesforce integration brings Verily AI into health system care team workflows.

### What is Verily and what areas of precision health does it work in?
Verily is an Alphabet-backed precision health company that combines AI, data analytics, clinical research, and connected devices to improve disease prevention, management, and clinical trial operations across chronic disease and mental health.

### What are Verily's main products and platforms?
Verily's portfolio includes Onduo (virtual care for chronic conditions), Verily Workbench (precision medicine research platform), Verily Study Watch (research-grade wearable), and clinical trial technology through its Baseline Health Study infrastructure.

### How does Verily support clinical research?
Verily provides clinical trial technology including decentralized trial infrastructure, participant recruitment tools, longitudinal health data collection, and AI-powered data analysis for pharmaceutical and biotech research partners.

### What chronic conditions does Verily's Onduo platform address?
Onduo provides virtual care and coaching for diabetes, hypertension, weight management, and mental health, combining connected devices, app-based coaching, and clinical care to improve chronic disease management outcomes.

## Tags

b2c, healthtech, mobile-first

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*